Creative Commons

AbbVie's hepatitis C drug, Viekira Pak, hasn't taken off like the competing drugs made by Gilead Sciences.

The drugmaker said Friday that sales of Viekira dropped 7% in 2016 to $1.5 billion. That's a lot of money, but Viekira is just 6% of AbbVie's total revenue. Sales in the United States alone dropped 57% last year. The core of AbbVie is its blockbuster Humira, which had more than $16 billion in sales in 2016.

Why this matters: When Viekira came to the market in 2015, it was seen as a potential competitor to Sovaldi and Harvoni, the two Gilead drugs that shook the health care world with their high prices. Like Sovaldi and Harvoni, Viekira had the ability to cure hepatitis C.

But even though Viekira scored a formulary deal with Express Scripts, it hasn't had the same widespread adoption. Part of the issue is Viekira was found to have some safety risks for hepatitis C patients who had more advanced liver disease. (This week, though, a new study found that Sovaldi and Harvoni may have side effects too.)

Go deeper

Updated 14 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 8 a.m. ET: 12,520,431 — Total deaths: 560,830 — Total recoveries — 6,900,718Map.
  2. U.S.: Total confirmed cases as of 8 a.m. ET: 3,184,722 — Total deaths: 134,830 — Total recoveries: 983,185 — Total tested: 38,856,341Map.
  3. Public health: The reality of the coronavirus bites.
  4. Trade: Trump says he's no longer considering phase-two trade deal with China because the pandemic damaged the two countries' relationship.
  5. 🎧 Podcast: Rural America has its own coronavirus problem.
1 hour ago - Health

We're losing the war on the coronavirus

Chart: Danielle Alberti/Axios

By any standard, no matter how you look at it, the U.S. is losing its war against the coronavirus.

Why it matters: The pandemic is not an abstraction, and it is not something that’s simmering in the background. It is an ongoing emergency ravaging nearly the entire country, with a loss of life equivalent to a Sept. 11 every three days — for four months and counting.

Trump commutes Roger Stone's sentence

Roger Stone arriving at his sentencing hearing on Feb. 20. Photo: Drew Angerer/Getty Images

President Trump on Friday evening commuted the sentence of his longtime associate Roger Stone, according to two senior administration officials. Stone in February was sentenced to 40 months in prison for crimes including obstruction, witness tampering and making false statements to Congress.

Why it matters: The controversial move brings an abrupt end to the possibility of Stone spending time behind bars. He had been scheduled to report to prison on July 14.